Patients with type 2 diabetes mellitus have higher plasma concentrations of pro-inflammatory cytokines, including IL-1β, IL-6, IL-8, IL-17, IL-18, TNF-α, IFN-γ, and TGF-β, according to research (T2DM). This evidence concerns the gene CXCL8 and type 2 diabetes mellitus.